NCT02856295View on ClinicalTrials.gov

anti10a Levels in Women Treated With LMWH in the Postpartum Period

PHASE4CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

November 20, 2021

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Venous Thromboembolism
Interventions
DRUG

clexane (LMWH)

to compare tow doses of clexane for preventing VTE in postpartum women

Trial Locations (1)

Unknown

Emek medical center, Afula

All Listed Sponsors
lead

HaEmek Medical Center, Israel

OTHER

NCT02856295 - anti10a Levels in Women Treated With LMWH in the Postpartum Period | Biotech Hunter | Biotech Hunter